Skip to Main Content

Author Details

Natalie E Dean
College of Public Health and Health Professions, University of Florida
2015
56
26
Wade Schulz (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36932663Covariate-constrained randomization with cluster selection and substitution.Clin Trials2023
37277329Estimating the impact of COVID-19 vaccine inequities: a modeling study.Nat Commun2023
37365505Rapid review and meta-analysis of serial intervals for SARS-CoV-2 Delta and Omicron variants.BMC Infect Dis2023
36848460Application of Phylodynamic Tools to Inform the Public Health Response to COVID-19: Qualitative Analysis of Expert Opinions.JMIR Form Res2023
35194954The prevalence of pre-treatment and acquired HIV drug resistance in Vietnam: a nationally representative survey, 2017-2018.J Int AIDS Soc2022
35384900Use of Recently Vaccinated Individuals to Detect Bias in Test-Negative Case-Control Studies of COVID-19 Vaccine Effectiveness.Epidemiology2022
35697361Change in covid-19 risk over time following vaccination with CoronaVac: test negative case-control study.BMJ2022
35366959Effectiveness of CoronaVac, ChAdOx1 nCoV-19, BNT162b2, and Ad26.COV2.S among individuals with previous SARS-CoV-2 infection in Brazil: a test-negative, case-control study.Lancet Infect Dis2022
35696558Quantifying the importance and location of SARS-CoV-2 transmission events in large metropolitan areas.Proc Natl Acad Sci U S A2022
35482308Household Secondary Attack Rates of SARS-CoV-2 by Variant and Vaccination Status: An Updated Systematic Review and Meta-analysis.JAMA Netw Open2022
36454733Association between primary or booster COVID-19 mRNA vaccination and Omicron lineage BA.1 SARS-CoV-2 infection in people with a prior SARS-CoV-2 infection: A test-negative case-control analysis.PLoS Med2022
36415459Estimating the impact of COVID-19 vaccine allocation inequities: a modeling study.medRxiv2022
36202800Effectiveness of an inactivated Covid-19 vaccine with homologous and heterologous boosters against Omicron in Brazil.Nat Commun2022
35271331Protecting the herd with vaccination.Science2022
35271324The changing epidemiology of SARS-CoV-2.Science2022
35057647The ring vaccination trial design for the estimation of vaccine efficacy and effectiveness during infectious disease outbreaks.Clin Trials2022
33476567Household transmission of SARS-CoV-2 and risk factors for susceptibility and infectivity in Wuhan: a retrospective observational study.Lancet Infect Dis2021
33883675SARS-CoV-2 shifting transmission dynamics and hidden reservoirs potentially limit efficacy of public health interventions in Italy.Commun Biol2021
33576387The Usefulness of the Test-Positive Proportion of Severe Acute Respiratory Syndrome Coronavirus 2 as a Surveillance Tool.Am J Epidemiol2021
33791745Cryptic transmission of SARS-CoV-2 and the first COVID-19 wave in Europe and the United States.medRxiv2021
34988559Change in COVID-19 risk over time following vaccination with CoronaVac: A testnegative case-control study.medRxiv2021
34496195Covid-19 Vaccine Effectiveness and the Test-Negative Design.N Engl J Med2021
34628108Challenges of evaluating and modelling vaccination in emerging infectious diseases.Epidemics2021
34448865Factors Associated With Household Transmission of SARS-CoV-2: An Updated Systematic Review and Meta-analysis.JAMA Netw Open2021
34218667Using simulated infectious disease outbreaks to inform site selection and sample size for individually randomized vaccine trials during an ongoing epidemic.Clin Trials2021
34001753Theoretical Framework for Retrospective Studies of the Effectiveness of SARS-CoV-2 Vaccines.Epidemiology2021
31135263Two-stage adaptive enrichment design for testing an active factor.J Biopharm Stat2020
33315116Household Transmission of SARS-CoV-2: A Systematic Review and Meta-analysis.JAMA Netw Open2020
33087460Understanding COVID-19 vaccine efficacy.Science2020
33032661The TIRS trial: protocol for a cluster randomized controlled trial assessing the efficacy of preventive targeted indoor residual spraying to reduce Aedes-borne viral illnesses in Merida, Mexico.Trials2020
32766596Household transmission of SARS-CoV-2: a systematic review and meta-analysis of secondary attack rate.medRxiv2020
32676609Estimating the establishment of local transmission and the cryptic phase of the COVID-19 pandemic in the USA.medRxiv2020
32759985Modelling the impact of testing, contact tracing and household quarantine on second waves of COVID-19.Nat Hum Behav2020
32415834Temporal Confounding in the Test-Negative Design.Am J Epidemiol2020
32242365Creating a Framework for Conducting Randomized Clinical Trials during Disease Outbreaks.N Engl J Med2020
32543881COVID-19 Clinical Trials: A Teachable Moment for Improving Our Research Infrastructure and Relevance.Ann Intern Med2020
32562601Household secondary attack rate of COVID-19 and associated determinants in Guangzhou, China: a retrospective cohort study.Lancet Infect Dis2020
32511590Household Secondary Attack Rate of COVID-19 and Associated Determinants.medRxiv2020
32511536Modeling the impact of social distancing, testing, contact tracing and household quarantine on second-wave scenarios of the COVID-19 epidemic.medRxiv2020
30689690RE: "MEASUREMENT OF VACCINE DIRECT EFFECTS UNDER THE TEST-NEGATIVE DESIGN".Am J Epidemiol2019
30741163Provincial and national prevalence estimates of transmitted HIV-1 drug resistance in South Africa measured using two WHO-recommended methods.Antivir Ther2019
29606991DESIGN OF VACCINE TRIALS DURING OUTBREAKS WITH AND WITHOUT A DELAYED VACCINATION COMPARATOR.Ann Appl Stat2018
29912708Avian Influenza A Virus Infection among Workers at Live Poultry Markets, China, 2013-2016.Emerg Infect Dis2018
30336778Quantifying the risk of local Zika virus transmission in the contiguous US during the 2015-2016 ZIKV epidemic.BMC Med2018
28017403Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola ÿa Suffit!).Lancet2017
28442561Spread of Zika virus in the Americas.Proc Natl Acad Sci U S A2017
29033032Ring vaccination with rVSV-ZEBOV under expanded access in response to an outbreak of Ebola virus disease in Guinea, 2016: an operational and vaccine safety report.Lancet Infect Dis2017
28743299The public health value of vaccines beyond efficacy: methods, measures and outcomes.BMC Med2017
26932131Transmissibility and Pathogenicity of Ebola Virus: A Systematic Review and Meta-analysis of Household Secondary Attack Rate and Asymptomatic Infection.Clin Infect Dis2016
27806049Containing Ebola at the Source with Ring Vaccination.PLoS Negl Trop Dis2016
  • 1 - 50 of 56

Recommended Authors

Johns Hopkins Bloomberg School of Public Health
Career Start Year 2017
Number of shared co-authors 0
University Hospital of Geneva
Career Start Year 2015
Number of shared co-authors 2
US Centers for Disease Control and Prevention
Career Start Year 2014
Number of shared co-authors 4
University of Bordeaux, Inserm, EUCLID/F-CRIN Clinical Trials Platform
Career Start Year 2013
Number of shared co-authors 0
US Centers for Disease Control and Prevention
Career Start Year 2013
Number of shared co-authors 3
Centers for Disease Control and Prevention
Career Start Year 2012
Number of shared co-authors 4
Dalla Lana School of Public Health, University of Toronto
Career Start Year 2012
Number of shared co-authors 4
Marshfield Clinic Research Institute
Career Start Year 2012
Number of shared co-authors 3
University of Maryland School of Medicine
Career Start Year 2011
Number of shared co-authors 0
University of Washington
Career Start Year 2010
Number of shared co-authors 2
University College London Hospitals National Health Service Foundation Trust
Career Start Year 2010
Number of shared co-authors 2
Department of Health Sciences Northeastern University
Career Start Year 2009
Number of shared co-authors 4
Hinton State Laboratory Institute
Career Start Year 2009
Number of shared co-authors 2
Yale School of Public Health, Yale University
Career Start Year 2008
Number of shared co-authors 5
Boston University
Career Start Year 2007
Number of shared co-authors 2
College of Public Health, University of Nebraska Medical Center
Career Start Year 2006
Number of shared co-authors 2
University of Michigan School of Public Health ann arbor
Career Start Year 2006
Number of shared co-authors 3
Centers for Disease Control and Prevention
Career Start Year 2005
Number of shared co-authors 4
Yale School of Public Health
Career Start Year 2004
Number of shared co-authors 9
Centers for Disease Control and Prevention
Career Start Year 2004
Number of shared co-authors 2
Frederick National Laboratory for Cancer Research
Career Start Year 2003
Number of shared co-authors 2
Geneva Center for Emerging Viral Diseases, Geneva University Hospitals
Career Start Year 2003
Number of shared co-authors 2
Boston Children's Hospital
Career Start Year 2002
Number of shared co-authors 2
Center for Infectious Diseases Research, Walter Reed Army Institute of Research
Career Start Year 2002
Number of shared co-authors 1
Kaiser Permanente Washington Health Research Institute
Career Start Year 1998
Number of shared co-authors 0
Centers for Disease Control and Prevention
Career Start Year 1998
Number of shared co-authors 5
Baylor Scott & White Health and Baylor College of Medicine
Career Start Year 1995
Number of shared co-authors 4
Centers for Disease Control and Prevention
Career Start Year 1995
Number of shared co-authors 3
London School of Hygiene & Tropical Medicine
Career Start Year 1995
Number of shared co-authors 2
Marshfield Clinic Research Institute
Career Start Year 1987
Number of shared co-authors 3

Collaborators

University of Washington, Fred Hutchinson Cancer Center
Co-authored papers 28
Co-authored papers 13
University of Florida
Co-authored papers 7
Co-authored papers 7
Instituto Goncalo Moniz, Yale School of Public Health
Co-authored papers 6
Stanford University
Co-authored papers 5
Federal University of Mato Grosso do Sul
Co-authored papers 5
Yale School of Public Health
Co-authored papers 5
Heart Institute (InCor), Faculdade de Medicina, Universidade de Sao Paulo
Co-authored papers 5
Co-authored papers 5
Co-authored papers 4
and the Institute of Social and Preventive Medicine, University of Bern
Co-authored papers 3
State University of Mato Grosso do Sul
Co-authored papers 3
Yale University
Co-authored papers 3
Massachusetts Institute of Technology
Co-authored papers 3
College of Public Health and Health Professions, University of Florida
Co-authored papers 2
Co-authored papers 2
Universidade de Brasilia
Co-authored papers 2
Co-authored papers 2
Universidade de Brasilia - Campus Universitario Darcy Ribeiro
Co-authored papers 2
Co-authored papers 1
Co-authored papers 1
Yale School of Public Health
Co-authored papers 1
Perelman School of Medicine, University of Pennsylvania
Co-authored papers 1
Yale School of Medicine
Co-authored papers 1
Universidade Federal de Mato Grosso do Sul - UFMS
Co-authored papers 1
Yale University School of Medicine
Co-authored papers 1
Yale School of Public Health
Co-authored papers 1
Co-authored papers 1
National Institute of Biomedical Research (INRB)
Co-authored papers 1